PBY
Puma Biotec
Stock
Stock
ISIN: US74587V1070
Ticker: PBYI
US74587V1070
PBYI
Price
Price
CHART BY
Frequently asked questions
What is Puma Biotec's market capitalization?
The market capitalization of Puma Biotec is $134.99M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Puma Biotec's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Puma Biotec is 5.79. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Puma Biotec?
Puma Biotec's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.475. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Puma Biotec's stock?
Currently, 3 analysts cover Puma Biotec's stock, with a consensus target price of $4.333. Analyst ratings provide insights into the stock's expected performance.
What is Puma Biotec's revenue over the trailing twelve months?
Over the trailing twelve months, Puma Biotec reported a revenue of $243.57M.
What is the EBITDA for Puma Biotec?
Puma Biotec's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $43.97M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Puma Biotec?
Puma Biotec has a free cash flow of $33.68M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Puma Biotec have, and what sector and industry does it belong to?
Puma Biotec employs approximately 185 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Puma Biotec's shares?
The free float of Puma Biotec is 34.86M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $134.99M
- EPS (TTM)
- $0.475
- Free Float
- 34.86M
- P/E ratio (TTM)
- 5.79
- Revenue (TTM)
- $243.57M
- EBITDA (TTM)
- $43.97M
- Free Cashflow (TTM)
- $33.68M
Pricing
- 52W span
- $2.23$7.73
Analyst Ratings
The price target is $4.333 and the stock is covered by 3 analysts.
Buy
1
Hold
1
Sell
1
Information
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
- Employees
- 185
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US74587V1070
- Primary Ticker
- PBYI